Clinical Implication of Serum Thyroglobulin in Recurred Papillary Thyroid Cancer at Neck Nodes
![]() |
Lee, Ha-Na
(Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine)
Han, Myung-Woul (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) Lee, Ho-Jun (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) Roh, Jong-Lyel (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) Nam, Soon-Yuhl (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) Kim, Sang-Yoon (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) Choi, Seung-Ho (Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Kim JH, Kim WB, Kim EY, Kim WG, Kim TY, Ryu JS, et al. The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab. In press;2011. |
2 | Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med. 2003;139:346-351. DOI |
3 | Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, et al. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2008;93:4683-4689. DOI ScienceOn |
4 | Zucchelli G, Iervasi A, Ferdeghini M, Iervasi G. Serum thyroglobulin measurement in the follow-up of patients treated for differentiated thyroid cancer. Q J Nucl Med Mol Imaging. 2009;53:482-489. |
5 | Black EG, Gassoni A, Gimlette TM, Harmer CL, Maisey MN, Oates GD, et al. Serum thyroglobulin in thyroid cancer. Lancet. 1981;2:443-445. |
6 | Herle AJ, Uller RP. Elevated serum thyroglobulin. A marker of metastasis in differentiated thyroid carcinomas. J Clin Invest. 1975;56:272-277. DOI |
7 | Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214. DOI ScienceOn |
8 | Hardy KJ, Walker BR, Lindsay RS, Kennedy RL, Seckl JR, Padfield PL. Thyroid cancer management. Clin Endocrinol. 1995;42:651-655. DOI ScienceOn |
9 | Bachelot A, Caileux AF, Klain M, Baudin E, Ricard M, Bellon N, et al. Relationship between tumor burden and serum thy-roglobulin level in patients with papillary and follicular thyroid carcinoma. Thyroid. 2002;12:707-711. DOI ScienceOn |
10 | Schlumberger M, Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Europ J Endocrinol. 1998;138:249-252. DOI ScienceOn |
![]() |